SI1691804T1 - Nitrooksi derivati karvedilola in drugih beta blokatorjev kot antihipertenzivi - Google Patents
Nitrooksi derivati karvedilola in drugih beta blokatorjev kot antihipertenziviInfo
- Publication number
- SI1691804T1 SI1691804T1 SI200430328T SI200430328T SI1691804T1 SI 1691804 T1 SI1691804 T1 SI 1691804T1 SI 200430328 T SI200430328 T SI 200430328T SI 200430328 T SI200430328 T SI 200430328T SI 1691804 T1 SI1691804 T1 SI 1691804T1
- Authority
- SI
- Slovenia
- Prior art keywords
- nitrooxyderivatives
- carvedilol
- beta blockers
- antihypertensive drugs
- antihypertensive
- Prior art date
Links
- 239000002220 antihypertensive agent Substances 0.000 title 1
- 229940127088 antihypertensive drug Drugs 0.000 title 1
- 239000002876 beta blocker Substances 0.000 title 1
- 229940097320 beta blocking agent Drugs 0.000 title 1
- NPAKNKYSJIDKMW-UHFFFAOYSA-N carvedilol Chemical class COC1=CC=CC=C1OCCNCC(O)COC1=CC=CC2=NC3=CC=C[CH]C3=C12 NPAKNKYSJIDKMW-UHFFFAOYSA-N 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C219/00—Compounds containing amino and esterified hydroxy groups bound to the same carbon skeleton
- C07C219/02—Compounds containing amino and esterified hydroxy groups bound to the same carbon skeleton having esterified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton
- C07C219/04—Compounds containing amino and esterified hydroxy groups bound to the same carbon skeleton having esterified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated
- C07C219/14—Compounds containing amino and esterified hydroxy groups bound to the same carbon skeleton having esterified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having at least one of the hydroxy groups esterified by a carboxylic acid having the esterifying carboxyl group bound to a carbon atom of a six-membered aromatic ring
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/06—Antiglaucoma agents or miotics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C219/00—Compounds containing amino and esterified hydroxy groups bound to the same carbon skeleton
- C07C219/02—Compounds containing amino and esterified hydroxy groups bound to the same carbon skeleton having esterified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton
- C07C219/04—Compounds containing amino and esterified hydroxy groups bound to the same carbon skeleton having esterified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated
- C07C219/06—Compounds containing amino and esterified hydroxy groups bound to the same carbon skeleton having esterified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having the hydroxy groups esterified by carboxylic acids having the esterifying carboxyl groups bound to hydrogen atoms or to acyclic carbon atoms of an acyclic saturated carbon skeleton
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C233/00—Carboxylic acid amides
- C07C233/01—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
- C07C233/30—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by doubly-bound oxygen atoms
- C07C233/33—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by doubly-bound oxygen atoms with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by a carbon atom of a six-membered aromatic ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C235/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms
- C07C235/02—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to acyclic carbon atoms and singly-bound oxygen atoms bound to the same carbon skeleton
- C07C235/04—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to acyclic carbon atoms and singly-bound oxygen atoms bound to the same carbon skeleton the carbon skeleton being acyclic and saturated
- C07C235/08—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to acyclic carbon atoms and singly-bound oxygen atoms bound to the same carbon skeleton the carbon skeleton being acyclic and saturated having the nitrogen atom of at least one of the carboxamide groups bound to an acyclic carbon atom of a hydrocarbon radical substituted by singly-bound oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C235/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms
- C07C235/42—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to carbon atoms of six-membered aromatic rings and singly-bound oxygen atoms bound to the same carbon skeleton
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C311/00—Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
- C07C311/01—Sulfonamides having sulfur atoms of sulfonamide groups bound to acyclic carbon atoms
- C07C311/02—Sulfonamides having sulfur atoms of sulfonamide groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton
- C07C311/08—Sulfonamides having sulfur atoms of sulfonamide groups bound to acyclic carbon atoms of an acyclic saturated carbon skeleton having the nitrogen atom of at least one of the sulfonamide groups bound to a carbon atom of a six-membered aromatic ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/56—Ring systems containing three or more rings
- C07D209/80—[b, c]- or [b, d]-condensed
- C07D209/82—Carbazoles; Hydrogenated carbazoles
- C07D209/88—Carbazoles; Hydrogenated carbazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the ring system
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2601/00—Systems containing only non-condensed rings
- C07C2601/06—Systems containing only non-condensed rings with a five-membered ring
- C07C2601/08—Systems containing only non-condensed rings with a five-membered ring the ring being saturated
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C2602/00—Systems containing two condensed rings
- C07C2602/02—Systems containing two condensed rings the rings having only two atoms in common
- C07C2602/04—One of the condensed rings being a six-membered aromatic ring
- C07C2602/10—One of the condensed rings being a six-membered aromatic ring the other ring being six-membered, e.g. tetraline
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Engineering & Computer Science (AREA)
- Ophthalmology & Optometry (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Indole Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP03104484 | 2003-12-02 | ||
| PCT/EP2004/013683 WO2005053685A1 (en) | 2003-12-02 | 2004-12-01 | Nitrooxyderivatives of carvedilol and other beta blockers as antihypertensive drugs |
| EP04803434A EP1691804B1 (en) | 2003-12-02 | 2004-12-01 | Nitrooxyderivatives of carvedilol and other beta blockers as antihypertensive drugs |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SI1691804T1 true SI1691804T1 (sl) | 2007-10-31 |
Family
ID=34639309
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SI200430328T SI1691804T1 (sl) | 2003-12-02 | 2004-12-01 | Nitrooksi derivati karvedilola in drugih beta blokatorjev kot antihipertenzivi |
Country Status (22)
| Country | Link |
|---|---|
| US (1) | US7825263B2 (sl) |
| EP (1) | EP1691804B1 (sl) |
| JP (1) | JP2007513114A (sl) |
| KR (1) | KR20060120677A (sl) |
| CN (1) | CN1886132A (sl) |
| AR (1) | AR047732A1 (sl) |
| AT (1) | ATE358478T1 (sl) |
| AU (1) | AU2004294297A1 (sl) |
| BR (1) | BRPI0416584A (sl) |
| CA (1) | CA2548129A1 (sl) |
| DE (1) | DE602004005748T2 (sl) |
| DK (1) | DK1691804T3 (sl) |
| ES (1) | ES2285549T3 (sl) |
| HR (1) | HRP20070283T3 (sl) |
| IL (1) | IL174959A0 (sl) |
| NO (1) | NO20063057L (sl) |
| PL (2) | PL380065A1 (sl) |
| PT (1) | PT1691804E (sl) |
| RU (1) | RU2006119528A (sl) |
| SI (1) | SI1691804T1 (sl) |
| WO (1) | WO2005053685A1 (sl) |
| ZA (1) | ZA200604458B (sl) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2004528337A (ja) | 2001-05-02 | 2004-09-16 | ニトロメド インコーポレーテッド | ニトロソ化およびニトロシル化ネビボロール、ならびにその代謝産物、組成物、および使用方法 |
| WO2007090733A1 (en) * | 2006-02-06 | 2007-08-16 | Nicox S.A. | Nitrooxy derivatives suitable as alpha2 adrenergic receptor agonists |
| US7799784B2 (en) | 2006-02-06 | 2010-09-21 | Nicox S.A. | Quinoxaline derivatives of alpha-2 adrenergic agonists |
| WO2008112287A1 (en) | 2007-03-12 | 2008-09-18 | Nektar Therapeutics | Oligomer-beta blocker conjugates |
| WO2008144247A1 (en) | 2007-05-14 | 2008-11-27 | Tyco Healthcare Group Lp | Antimicrobial materials and coatings |
| US8062653B2 (en) * | 2009-02-18 | 2011-11-22 | Bezwada Biomedical, Llc | Controlled release of nitric oxide and drugs from functionalized macromers and oligomers |
| US11420995B2 (en) | 2017-03-03 | 2022-08-23 | Synovo Gmbh | Anti-infective and anti-inflammatory compounds |
| CN115246774A (zh) * | 2021-04-27 | 2022-10-28 | 南昌弘益科技有限公司 | 一类新型双羰基类阿魏酸衍生物 |
Family Cites Families (13)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE2805404A1 (de) * | 1978-02-09 | 1979-08-16 | Merck Patent Gmbh | 1-aryloxy-3-nitratoalkylamino-2-propanole und verfahren zu ihrer herstellung |
| DE3443998A1 (de) * | 1984-12-01 | 1986-06-05 | Boehringer Mannheim Gmbh, 6800 Mannheim | Amino-propanol-derivate, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel sowie zwischenprodukte |
| DE3512627A1 (de) | 1985-04-06 | 1986-10-09 | Boehringer Mannheim Gmbh, 6800 Mannheim | Amino-propanol-derivate, verfahren zu deren herstellung, verwendung derselben und diese enthaltende arzneimittel |
| ES2065291B1 (es) * | 1993-07-30 | 1995-10-01 | Prodesfarma Sa | "nitrato esteres de 1-ariloxi-3-alquilamino-2-propanoles, utilizacion y composicion farmaceutica correspondiente" |
| US5932538A (en) * | 1996-02-02 | 1999-08-03 | Nitromed, Inc. | Nitrosated and nitrosylated α-adrenergic receptor antagonist compounds, compositions and their uses |
| IT1295694B1 (it) | 1996-11-14 | 1999-05-27 | Nicox Sa | Nitrossi derivati per la preparazione di medicamenti ad attivita antitrombinica |
| PE20001302A1 (es) * | 1998-11-27 | 2000-11-30 | Hoffmann La Roche | Preparaciones de una combinacion farmaceutica que contiene carvedilol e hidroclorotiazida |
| IT1311923B1 (it) * | 1999-04-13 | 2002-03-20 | Nicox Sa | Composti farmaceutici. |
| IT1311924B1 (it) * | 1999-04-13 | 2002-03-20 | Nicox Sa | Composti farmaceutici. |
| IT1314184B1 (it) * | 1999-08-12 | 2002-12-06 | Nicox Sa | Composizioni farmaceutiche per la terapia di condizioni di stressossidativo |
| WO2002078692A1 (en) * | 2001-04-02 | 2002-10-10 | Smithkline Beecham Corporation | Method of treatment |
| WO2002100824A1 (en) * | 2001-05-28 | 2002-12-19 | Chemtech Research Incorporation | A novel alkaloid derivative and a pharmaceutical composition containing the same |
| ITMI20020148A1 (it) * | 2002-01-29 | 2003-07-29 | Nicox Sa | Nuovi corticosteroidi |
-
2004
- 2004-12-01 JP JP2006541892A patent/JP2007513114A/ja active Pending
- 2004-12-01 SI SI200430328T patent/SI1691804T1/sl unknown
- 2004-12-01 AU AU2004294297A patent/AU2004294297A1/en not_active Abandoned
- 2004-12-01 AR ARP040104485A patent/AR047732A1/es not_active Application Discontinuation
- 2004-12-01 DE DE602004005748T patent/DE602004005748T2/de not_active Expired - Lifetime
- 2004-12-01 PT PT04803434T patent/PT1691804E/pt unknown
- 2004-12-01 DK DK04803434T patent/DK1691804T3/da active
- 2004-12-01 HR HR20070283T patent/HRP20070283T3/xx unknown
- 2004-12-01 EP EP04803434A patent/EP1691804B1/en not_active Expired - Lifetime
- 2004-12-01 AT AT04803434T patent/ATE358478T1/de not_active IP Right Cessation
- 2004-12-01 CN CNA200480035459XA patent/CN1886132A/zh active Pending
- 2004-12-01 RU RU2006119528/04A patent/RU2006119528A/ru not_active Application Discontinuation
- 2004-12-01 WO PCT/EP2004/013683 patent/WO2005053685A1/en not_active Ceased
- 2004-12-01 ES ES04803434T patent/ES2285549T3/es not_active Expired - Lifetime
- 2004-12-01 PL PL380065A patent/PL380065A1/pl not_active Application Discontinuation
- 2004-12-01 PL PL04803434T patent/PL1691804T3/pl unknown
- 2004-12-01 BR BRPI0416584-5A patent/BRPI0416584A/pt not_active IP Right Cessation
- 2004-12-01 CA CA002548129A patent/CA2548129A1/en not_active Abandoned
- 2004-12-01 US US10/577,912 patent/US7825263B2/en not_active Expired - Fee Related
- 2004-12-01 KR KR1020067010491A patent/KR20060120677A/ko not_active Withdrawn
-
2006
- 2006-03-31 ZA ZA200604458A patent/ZA200604458B/xx unknown
- 2006-04-11 IL IL174959A patent/IL174959A0/en unknown
- 2006-06-30 NO NO20063057A patent/NO20063057L/no not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| PL380065A1 (pl) | 2006-12-11 |
| CN1886132A (zh) | 2006-12-27 |
| EP1691804B1 (en) | 2007-04-04 |
| HRP20070283T3 (en) | 2007-11-30 |
| DE602004005748T2 (de) | 2007-12-27 |
| DK1691804T3 (da) | 2007-07-16 |
| KR20060120677A (ko) | 2006-11-27 |
| ATE358478T1 (de) | 2007-04-15 |
| AU2004294297A1 (en) | 2005-06-16 |
| DE602004005748D1 (de) | 2007-05-16 |
| ZA200604458B (en) | 2007-04-25 |
| PT1691804E (pt) | 2007-07-04 |
| BRPI0416584A (pt) | 2007-01-30 |
| WO2005053685A1 (en) | 2005-06-16 |
| AR047732A1 (es) | 2006-02-15 |
| CA2548129A1 (en) | 2005-06-16 |
| ES2285549T3 (es) | 2007-11-16 |
| NO20063057L (no) | 2006-06-30 |
| PL1691804T3 (pl) | 2007-08-31 |
| IL174959A0 (en) | 2006-08-20 |
| US20070072854A1 (en) | 2007-03-29 |
| RU2006119528A (ru) | 2008-01-10 |
| JP2007513114A (ja) | 2007-05-24 |
| EP1691804A1 (en) | 2006-08-23 |
| US7825263B2 (en) | 2010-11-02 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| AU2003223207A8 (en) | Scds as modifiers of the p53 pathway and methods of use | |
| EP1594467A4 (en) | MISUSE OF PHARMACEUTICAL COMPOSITIONS OF OPIOIDES AND OTHER MEDICAMENTS | |
| IL166366A0 (en) | Aryl substituted benzimidazoles and their use as sodium channel blockers | |
| PL1615622T3 (pl) | Preparaty doksycyklin do jednorazowego dziennego podawania | |
| IL164438A0 (en) | Sustaubed release of guaifenesin combination drugs | |
| AU2003277876A1 (en) | Modified release formulations of oxcarbazepine and derivatives thereof | |
| GB0202900D0 (en) | Novel formulations of drugs | |
| ZA200604458B (en) | Nitrooxyderivatives of carvedilol and other beta blockers as antihypertensive drugs | |
| EP1539780A4 (en) | MONOSACCHARIDE DERIVATIVES FOR THE PREPARATION OF MEDICAMENTS | |
| IL166337A0 (en) | Oral administration of calctionin | |
| PL1740204T3 (pl) | Lecznicze zastosowanie alfa-mannozydazy | |
| GB0207623D0 (en) | Crystal structure of g-quadruplex | |
| IL176061A0 (en) | Nitrooxyderivatives of antihypertensive drugs | |
| AU2003262141A8 (en) | Preperation of desloratatine | |
| AU2003295713A8 (en) | Methods of providing controlled-release pharmaceutical compositions and controlled-release pharmaceutical compositions | |
| IL177649A0 (en) | Method of preparing benzazepines and derivatives thereof | |
| AU2003298725A8 (en) | Preparation of metallotexaphyrins | |
| TW554970U (en) | Hollow structure of ceramic bearing | |
| IL165356A0 (en) | Preparation of 4-haloalkylkylnicotinamides | |
| TW573539U (en) | Improved structure of pacifier | |
| EP1832660A4 (en) | METHOD FOR SCREENING A MEDICAMENT AGAINST OBESITY | |
| GB0221822D0 (en) | Preparation of artemisinin derivatives | |
| TW578557U (en) | Structure of wearable dribbler stand | |
| TW566199U (en) | Structure of earplug | |
| TW579846U (en) | Improved structure of wheelchair |